chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Constipation, Diarrhoea, Dizziness
Clinical narrative: severe fever; chills; joint pain; muscle pain; extreme headaches; constipation; frequent urination; extremely tired; very severe rash/systemic rash/very bad, extreme rash/ rashes all over my body; nausea; diarrhea; rapid heart beat at times; extreme dizziness; Severe allergic reactions; Many allergic reactions; This is a spontaneous report from a contactable consumer (patient). A 75-years-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: EW0182, Expiry Date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Jul2021 (at the age of 75-year-old) as dose 1, single for COVID-19 immunization. No Medical history was reported. The patient's concomitant medications were not reported. On an unknown date in 2021, the patient had severe allergic reactions to first dose of the Pfizer vaccine. How do patient report the allergies?. The patient treatment included very many allergic reactions, I have taken Benadryl allergy medication, it was an over the counter product. The patient stated that have not seen a medical doctor yet (not clarified further). It was stated that sever fever began on the evening of 27Jul2021, I was at home. Patient further stated, "I had severe fever, chills, joint pain, muscle pain, extreme headaches, constipation, frequent urination, extremely tired and a very severe rash which I have had, nausea, diarrhea and a rapid heart beat at times in 2021. The worst which still remains was the 'systemic rash' (not clear), very bad, extreme rash in 2021 and was not going to take the second dose, it was on 18Aug2021, I need to know how to cancel that. The patient wanted to add that had extreme dizziness and the rashes all over my body in 2021." The patient received treatment with Tylenol for all events. Reporter seriousness for the events was Unspecified. Outcome of the event severe rash/systemic rash/very bad/extreme rash/ rashes all over my body was not recovered and outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate, Heart rate increased, Hypersensitivity
Clinical narrative: severe fever; chills; joint pain; muscle pain; extreme headaches; constipation; frequent urination; extremely tired; very severe rash/systemic rash/very bad, extreme rash/ rashes all over my body; nausea; diarrhea; rapid heart beat at times; extreme dizziness; Severe allergic reactions; Many allergic reactions; This is a spontaneous report from a contactable consumer (patient). A 75-years-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: EW0182, Expiry Date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Jul2021 (at the age of 75-year-old) as dose 1, single for COVID-19 immunization. No Medical history was reported. The patient's concomitant medications were not reported. On an unknown date in 2021, the patient had severe allergic reactions to first dose of the Pfizer vaccine. How do patient report the allergies?. The patient treatment included very many allergic reactions, I have taken Benadryl allergy medication, it was an over the counter product. The patient stated that have not seen a medical doctor yet (not clarified further). It was stated that sever fever began on the evening of 27Jul2021, I was at home. Patient further stated, "I had severe fever, chills, joint pain, muscle pain, extreme headaches, constipation, frequent urination, extremely tired and a very severe rash which I have had, nausea, diarrhea and a rapid heart beat at times in 2021. The worst which still remains was the 'systemic rash' (not clear), very bad, extreme rash in 2021 and was not going to take the second dose, it was on 18Aug2021, I need to know how to cancel that. The patient wanted to add that had extreme dizziness and the rashes all over my body in 2021." The patient received treatment with Tylenol for all events. Reporter seriousness for the events was Unspecified. Outcome of the event severe rash/systemic rash/very bad/extreme rash/ rashes all over my body was not recovered and outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pollakiuria, Pyrexia, Rash
Clinical narrative: severe fever; chills; joint pain; muscle pain; extreme headaches; constipation; frequent urination; extremely tired; very severe rash/systemic rash/very bad, extreme rash/ rashes all over my body; nausea; diarrhea; rapid heart beat at times; extreme dizziness; Severe allergic reactions; Many allergic reactions; This is a spontaneous report from a contactable consumer (patient). A 75-years-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot Number: EW0182, Expiry Date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Jul2021 (at the age of 75-year-old) as dose 1, single for COVID-19 immunization. No Medical history was reported. The patient's concomitant medications were not reported. On an unknown date in 2021, the patient had severe allergic reactions to first dose of the Pfizer vaccine. How do patient report the allergies?. The patient treatment included very many allergic reactions, I have taken Benadryl allergy medication, it was an over the counter product. The patient stated that have not seen a medical doctor yet (not clarified further). It was stated that sever fever began on the evening of 27Jul2021, I was at home. Patient further stated, "I had severe fever, chills, joint pain, muscle pain, extreme headaches, constipation, frequent urination, extremely tired and a very severe rash which I have had, nausea, diarrhea and a rapid heart beat at times in 2021. The worst which still remains was the 'systemic rash' (not clear), very bad, extreme rash in 2021 and was not going to take the second dose, it was on 18Aug2021, I need to know how to cancel that. The patient wanted to add that had extreme dizziness and the rashes all over my body in 2021." The patient received treatment with Tylenol for all events. Reporter seriousness for the events was Unspecified. Outcome of the event severe rash/systemic rash/very bad/extreme rash/ rashes all over my body was not recovered and outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Fatigue, Illness, Loss of personal independence in daily activities
Clinical narrative: very fatigued; feeling sick/really sick; has no energy whatsoever; she was in bed all the time; can't function; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0177), dose 1 via an unspecified route of administration on 15May2021 (at the age of 73 year) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure and blood cholesterol (take medications, those two go together, all of a sudden she can't think). The patient's concomitant medications were not reported. Consumer clarified that she got the vaccine, and the first day, and she didn't feel it on her arms or things. Then, on 16May2021, the next day, consumer had fatigue in the morning. Consumer said that she felt ok after lunch, afternoon she was very fatigued and sick afterwards and all her energy was gone and her eyes hardly opened, she was in bed all the time, and used something Nichi Glucan for events. Stated that it seemed to help some for half day, but that medicine was gone. She was still suffering, but not every day. She just laid down and felt asleep. She said she took a nap, and she get up and still has the sickness, it's been going on every day. She said something about her daughter called her and told her she went on the internet and something about a company had 30 years ago. Consumer said she did something and still has sickness. She said she got the Pfizer vaccine and wants to know how long this can last? has anybody called for the same thing and were there any medications for her to take, not aspirin or anything like that since she didn't have bad pain? She has sickness and on an unspecified date in May2021 can't function, she finished what medication she got, that was done. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101008502 same reporter, same drug/event, different patient;US-PFIZER INC-202101008504 same reporter, same drug/event, different patient
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymphadenopathy
Clinical narrative: her breasts feel like burning when eating spicy food; thinks the burning sensation is due to her lymph nodes being affected; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 51-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 31Jul2021 (age at vaccination was 51 years) as dose 1, single for COVID-19 immunization. The patient medical history included ongoing blood pressure high and lumpectomy (She had surgery. She had a lumpectomy in her right breast like 5 years ago and she felt in more in that breast more so). Concomitant medication included atenolol, chlortalidone (ATENOLOL CHLORTHALIDONE) taken for blood pressure high. No other vaccine was administered within four weeks prior to the first administration of COVID vaccine. The caller stated that she only had one shot and she never had, only one vaccination for COVID and no other vaccine. The caller stated she got the shot of the Pfizer Biontech COVID vaccine last Saturday. She said her breasts felt like burning when eating spicy food on an unspecified date. She noticed last 2 times she had something spicy her breast started burning inside. Every time she eats some spicy her breast hurts. She asked if that was normal. She never had this before her whole life. The caller said she was aware that the Pfizer Biontech COVID vaccine affects mammograms and it does something to sonograms as well. The caller asked if it had something to do with her lymph nodes because she thought the burning sensation was due to her lymph nodes being affected on an unspecified date. She stated that she knew it does something to the women's lymph nodes that's why she wanted to know what the problem was. The date of second shot was reported as 21Aug2021. The outcome of the events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer. This consumer reported for a 15-year-old female patient (reporter's Daughter) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0191 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 04Jun2021 (age at vaccination: 15 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm Right on 14May2021 (age at vaccination: 15 years), as a single dose for COVID-19 immunization. On an unspecified date, the patient has been experiencing headache everyday since that injection. The reporter asked was that something that was normal or should the headaches have gone away. The patient received Tylenol as treatment for the event. Outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscular weakness, Nausea, Pain in extremity
Clinical narrative: Muscle weakness; Headache; Nausea; Fatigue; Arm soreness; This is a spontaneous report from a non-contactable nurse, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Jul2021 (at the age of 39-years-old) as a single dose for COVID-19 immunization. Medical history included T 1 (type 1) diabetic (well controlled). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 23Jul2021, the patient experienced headache, nausea, fatigue, arm soreness and muscle weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events headache, nausea, fatigue, arm soreness and muscle weakness was recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Fever of 100.2; Chills; Headache; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Aug2021 at 10:30 (at the age of 30-year-old) as a single dose for COVID-19 immunization. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified medications within two weeks of vaccination. The patient previously received ceftriaxone sodium (ROCEPHIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Jul2021 at 09:30 (at the age of 30-year-old) as a single dose for COVID-19 immunization. On 08Aug2021 at 02:00, the patient had fever of 100.2, chills, headache and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 08Aug2021, the patient body temperature was measured and result was 100.2 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever of 100.2, chills, headache and muscle pain were not recovered at the time of this report.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Glossitis, Tongue discomfort
Clinical narrative: Irritated tongue; Irritated tongue, Feels like it has been scalded.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 21May2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 30Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 03Jun2021, the patient experienced irritated tongue that felt like it had been scalded. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events irritated tongue, feels like it has been scalded was not resolved at the time of this report.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Malaise, Parosmia
Clinical narrative: General malaise; symptoms others described; Smelling idk chemical or metal smell from skin; This is a spontaneous report from a contactable nurse, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6207) via an unspecified route of administration in the left arm on 14Mar2021 at 11:00 (at the age of 62-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included Systemic Lupus, Sjogren's and stage 4 splenic lymphoma rare. The patient was allergic to milk and adhesive in bandages. Concomitant medications included unspecified medications (MANUFACTURER UNKNOWN) for stage 4 non-Hodgkin lymphoma. The patient previously took pethidine hydrochloride (DEMEROL) and morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Jun2021 at 12:00, the patient experienced general malaise and symptoms others described. The patient's was a bit worse because she was fighting stage 4 non-Hodgkin lymphoma, a rare spleen cancer with immunotherapy. Her last treatment was over 8 months back. The patient kept smelling chemical or metal smell from her skin. It was bizarre. She was sure that it was nothing and she was on too many medications to plug them in. If the list was asked she would take a screenshot and send it. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events general malaise, symptoms others described and kept smelling chemical or metal smell from her skin were not resolved at the time of this report.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Vaccination site pain
Clinical narrative: The day after injection she had a migraine all day; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Aug2021 at 15:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included bad cholesterol and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Aug2021 at 00:00, the day after the injection, the patient experienced migraine all day and injection site pain. Therapeutic measures were not taken as a result of the events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events migraine all day and injection site pain were recovered on an unknown date in Aug2021.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Contusion, Haematoma
Clinical narrative: Two weeks after vaccine developed 17 black and blue marks with hematoma all at once for no reason.; Two weeks after vaccine developed 17 black and blue marks with hematoma all at once for no reason; This is a spontaneous report from a contactable consumer, the patient. An 81-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6708) via an unspecified route of administration in the left arm on 21Mar2021 at 16:00 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. Medical history included slightly low red blood cells and platelets. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, two weeks after vaccine, the patient developed 17 black and blue marks with hematoma all at once for no reason. A few weeks later, on an unknown date in 2021, the patient underwent blood tests and the result was lowered platelet and red blood cells. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed 17 black and blue marks with hematoma all at once for no reason was resolved with sequalae on an unknown date in 2021.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a non-contactable consumer (patient's friend) from Regulatory Authority. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date. The outcome of event was unknown. The patient also received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number was not reported) on an unspecified date for COVID-19 immunisation and experienced knocked them down for 4 or 5 days.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Hypoaesthesia, Pyrexia
Clinical narrative: Hair loss, globs and globs of hair loss; Fever for 5 days; Facial numbness; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the left arm on 17Feb2021 at 09:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hypothyroidism, anxiety and arthritis. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), labetalol (MANUFACTURER UNKNOWN), furosemide (LASIX) and levothyroxine (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Feb2021 at 00:00, the patient experienced hair loss, globs and globs of hair loss, fever for five days and facial numbness. The events resulted into doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever was recovered on 23Feb2021, while that of the event- hair loss, globs and globs of hair loss and facial numbness were unknown at the time of this report.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test abnormal, Cardiomegaly, Coronary angioplasty, Dyspnoea, Echocardiogram
Clinical narrative: On 20 Aug 21 I began feeling heart attack like symptoms to include heart palpitations, shortness of breath, and pain radiating down my left arm. I went to the Emergency Room who transferred me to another Hospital for admittance. Since being discharged I have received a prescription for Ramipril and have not received any other prescriptions or treatment.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Enzyme abnormality, Magnetic resonance imaging heart, Pain, Pain in extremity
Clinical narrative: On 20 Aug 21 I began feeling heart attack like symptoms to include heart palpitations, shortness of breath, and pain radiating down my left arm. I went to the Emergency Room who transferred me to another Hospital for admittance. Since being discharged I have received a prescription for Ramipril and have not received any other prescriptions or treatment.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, X-ray
Clinical narrative: On 20 Aug 21 I began feeling heart attack like symptoms to include heart palpitations, shortness of breath, and pain radiating down my left arm. I went to the Emergency Room who transferred me to another Hospital for admittance. Since being discharged I have received a prescription for Ramipril and have not received any other prescriptions or treatment.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Experienced heart racing for 2 days after each dose.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the right arm on an unknown date in 2021 and also the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the right arm on 12Jul2021 at 10:00 as a single dose for COVID-19 immunisation. Medical history included allergic to cranberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included acetylsalicylic acid (ASPIRIN) and ibuprofen (MOTRIN); both for unspecified indication and unknown date. On 13Jul2021 at 13:00, the patient experienced, heart racing for 2 days after each dose. Most significant was after the second pfizer. Patient stated that she had trouble getting heart rate down. The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event experienced heart racing for 2 days after each dose was recovered on an unknown date in 2021.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in fingertips; Tingling in fingertips; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 26Mar2021 (at the age of 20-year-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 16Apr2021 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced numbness and tingling in fingertips. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event numbness and tingling in fingertips was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: After 48 hours still running a fever around 99.5; Injection site is red; Tender to touch; Swollen knot about baseball size.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: FC3180) via an unspecified route of administration in the left arm on 06Aug2021 at 19:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, type II diabetes mellitus, hypothyroidism, and obese. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient received unspecified medications in two weeks. The patient had no known allergies. On 08Aug2021, after 48 hours of vaccination, the patient experienced  fever which was still running around 99.5 (unspecified units), her injection site was red, tender to touch and swollen knot about baseball size. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 99.5 (unspecified units), injection site red, tender to touch and swollen knot about baseball size were not recovered at the time of this report.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Lymphadenopathy, Migraine, Pyrexia
Clinical narrative: Fever; Migraine; Joint pain; Weakness; Swollen lymph node in an of injection; This is a spontaneous report from a contactable healthcare professional. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 07Aug2021 at 12:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, depression, chronic back pain and unspecified allergy. The patient received unspecified other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Aug2021 at 08:00, the patient experienced fever, migraine, joint pain, weakness and swollen lymph node in an of injection. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, migraine, joint pain, weakness and swollen lymph node in an of injection were not recovered at the time of this report.  The batch/lot number for BNT162b2, was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic fatigue syndrome
Clinical narrative: Chronic fatigue syndrome symptoms; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Jul2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 25Jul2021, the patient experienced chronic fatigue syndrome symptoms. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of event chronic fatigue syndrome symptoms was not resolved at the time of the report.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Body ache; Headache; Nausea; Chills; Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination.  On an unknown date, the patient experienced headache, nausea, body ache, chills, fever and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, body ache, chills, fever and fatigue was unknown at the time of this report.  The lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body ache; Headache; Nausea; Chills; Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination.  On an unknown date, the patient experienced headache, nausea, body ache, chills, fever and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, body ache, chills, fever and fatigue was unknown at the time of this report.  The lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Vaccination site urticaria
Clinical narrative: Sore Joints; Sore Joints and Muscles; welt at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Aug2021 at 13:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN) 60 mg from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Jul2021 at 12:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 07Aug2021, the patient experienced sore joints and muscles and welt at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with aspirin. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events sore joints and muscles and welt at injection site was recovering at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rash, Rash pruritic
Clinical narrative: Rash covering arm and torso area, excluding the back region. Also on upper legs. Went from itchy to painful accompanied by headache and tiredness.; Rash covering arm and torso area, excluding the back region. Also on upper legs. Went from itchy to painful accompanied by headache and tiredness.; Headache; tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 06Aug2021 at 11:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FA6780) via an unspecified route of administration in the left arm on 15Jul2021 at 18:00 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Aug2021 at 10:00, the patient experienced rash covering arm and torso area, excluding the back region, also on upper legs, went from itchy to painful accompanied by headache and tiredness. No fever involved. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash covering arm and torso area, excluding the back region also on upper legs, went from itchy to painful accompanied by headache and tiredness was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Weakness in legs; Joint pain in finger; Dizziness/weakness; Dizziness/weakness; Headache; Bad chills; Tiredness; Nausea; Feeling unwell; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Muscle pain; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included antinuclear factor abnormal (ANA levels) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191), via an unspecified route of administration in the left arm on 07Jul2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Aug2021 at 11:00, the patient experienced weakness in legs, joint pain in fingers, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness in legs, joint pain in finger, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes was not recovered at the time of this report.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Malaise, Muscular weakness, Myalgia
Clinical narrative: Weakness in legs; Joint pain in finger; Dizziness/weakness; Dizziness/weakness; Headache; Bad chills; Tiredness; Nausea; Feeling unwell; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Muscle pain; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included antinuclear factor abnormal (ANA levels) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191), via an unspecified route of administration in the left arm on 07Jul2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Aug2021 at 11:00, the patient experienced weakness in legs, joint pain in fingers, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness in legs, joint pain in finger, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes was not recovered at the time of this report.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Weakness in legs; Joint pain in finger; Dizziness/weakness; Dizziness/weakness; Headache; Bad chills; Tiredness; Nausea; Feeling unwell; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Injection site pain/swelling/redness; Muscle pain; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191) via an unspecified route of administration in the left arm on 02Aug2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included antinuclear factor abnormal (ANA levels) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0191), via an unspecified route of administration in the left arm on 07Jul2021 at 11:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Aug2021 at 11:00, the patient experienced weakness in legs, joint pain in fingers, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness in legs, joint pain in finger, dizziness/weakness, headache, bad chills, tiredness, nausea, feeling unwell, injection site pain/ swelling/ redness, muscle pain and swollen lymph nodes was not recovered at the time of this report.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle spasms, Musculoskeletal stiffness, Pain in extremity, Paraesthesia
Clinical narrative: Muscle spasms in neck; upper back stiffness; Pain in both arm (from shoulder to hands); numbness & tingling in both fingers/hands; numbness & tingling in both fingers/hands; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 27Jul2021 at 11:00 (at the age of 15-years-old), as a single dose for COVID-19 immunisation. Medical history included wolff-parkinson-white syndrome (WPW) and enlarged aortic root. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any other medications within 2 weeks prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jul2021 at 09:30, the patient had experienced muscle spasms in neck/ upper back stiffness and pain in both arm from shoulder to hands, numbness and tingling in both fingers or hands. Since the vaccination, the patient had not been tested for COVID-19. The events had resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of events muscle spasms in neck/ upper back, stiffness and pain in both arm from shoulder to hands, numbness and tingling in both fingers or hands and included treatment with tylenol, motrin and valium. The clinical outcome of the events, muscle spasms in neck/ upper back, stiffness and pain in both arm from shoulder to hands, numbness and tingling in both fingers or hands was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.